跳至主要内容
临床试验/CTRI/2022/07/044182
CTRI/2022/07/044182已完成3 期

Assessing effectiveness of combined therapy of antioxidant and topical 5% imiquimod in management of oral leukoplakia – A randomised clinical trial

Dr Vijayalakshmi KR0 个研究点目标入组 60 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients between 18 to 70 years of age
  • Patients with clinically and histopathologically confirmed oral leukoplakia
  • Patients willing to be a part of the study and agreeing for the follow-up duration

排除标准

  • Pregnant and lactating patients
  • Patients undergoing treatment for leukoplakia or any other oral potentially malignant disorder (OPMD) or other systemic pre-cancerous or cancerous conditions
  • Patient allergic to toluidine blue dye and/ or imiquimod

研究者

发起方
Dr Vijayalakshmi KR

相似试验